Skip to main content
VIOL Co., Ltd. logo

VIOL Co., Ltd. — Investor Relations & Filings

Ticker · 335890 ISIN · KR7335890000 KO Manufacturing
Filings indexed 255 across all filing types
Latest filing 2025-06-18 M&A Activity
Country KR South Korea
Listing KO 335890

About VIOL Co., Ltd.

https://violmedical.com/

VIOL Co., Ltd. is a medical device company that researches, develops, and manufactures equipment for the medical aesthetics market. The company specializes in radiofrequency (RF) microneedling technology designed for skincare treatment, facial rejuvenation, and recovery. Its primary products include the Sylfirm X, Sylfirm, and Scarlet series of RF microneedling systems. The flagship Sylfirm X platform features dual-waveform technology (pulsed and continuous wave) that enables practitioners to treat a wide range of dermatological conditions, including skin laxity, pigmentation, and vascular lesions. VIOL's devices are developed to provide minimally invasive and effective solutions for medical professionals.

Recent filings

Filing Released Lang Actions
공개매수설명서
M&A Activity Classification · 1% confidence The document is a '공개매수설명서' (Tender Offer Statement) filed with the Financial Services Commission (금융위원회) regarding the company '비올' (VIOL CO., Ltd.). It details the intent of '주식회사 비엔나투자목적회사' to acquire shares of the target company for the purpose of M&A and voluntary delisting. This falls under the category of M&A activity and takeover bids.
2025-06-18 Korean
최대주주변경을수반하는주식양수도계약체결
Major Shareholding Notification Classification · 1% confidence The document is a formal regulatory announcement regarding a 'Change in Largest Shareholder' (최대주주 변경) resulting from a stock purchase and sale agreement (주식양수도 계약). This type of filing is a standard corporate disclosure in South Korean markets (DART system) concerning significant changes in ownership structure and control. Since it involves a change in the controlling shareholder, it falls under the category of M&A activity/corporate control changes, which is best classified as TAR (M&A Activity) within the provided schema.
2025-06-18 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 비올' (VIOL CO., Ltd.) covering the period from 2025-01-01 to 2025-03-31. It contains detailed financial statements, business operations, management analysis, and governance information, which are characteristic of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
소속부변경
Regulatory Filings Classification · 1% confidence The document is a short, formal announcement regarding a change in the company's market classification (from 'Mid-sized Enterprise' to 'Venture Enterprise') on the stock exchange. It does not contain full financial statements, board changes, or other specific categories, making it a general regulatory announcement.
2025-04-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend declarations, and board appointments. Since it reports the official outcomes of shareholder votes at the AGM, it falls under the 'Declaration of Voting Results & Voting Rights Announcements' category.
2025-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from the Korean stock exchange (KRX) titled 'Audit Report Submission' (감사보고서 제출). It provides the auditor's opinion, key financial data (assets, liabilities, revenue, profit), and confirmation of the audit completion for the fiscal year. While it contains financial data, it is a summary disclosure of the audit results rather than the full Annual Report (10-K) or a standalone Audit Report (AR) document. In the context of Korean regulatory filings (DART/KIND), this specific disclosure format is categorized as an Audit Report submission announcement. FY 2024
2025-03-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.